These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4283625

  • 1. Components of the fibrinolytic system in synovial joints. Normal bovine compared with normal and abnormal human synovial joints.
    Caughey DE, Highton TC.
    Ann Rheum Dis; 1967 Jul; 26(4):297-305. PubMed ID: 4283625
    [No Abstract] [Full Text] [Related]

  • 2. Relation between synovial joint and fibrinolytic activity of synovial fluid.
    Aoike I, Tominaga T, Horiuchi H, Arai T, Mizue S.
    Bull Tokyo Med Dent Univ; 1966 Jun; 13(2):77-95. PubMed ID: 4224976
    [No Abstract] [Full Text] [Related]

  • 3. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T, Lecander I, Geborek P.
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of surfactant proteins A, B, C, and D in articular cartilage, synovial membrane and synovial fluid of healthy as well as patients with osteoarthritis and rheumatoid arthritis.
    Hartjen N, Bräuer L, Reiß B, Claassen H, Beileke S, Garreis F, Hoogeboom S, Tsokos M, Etzold S, Müller-Hilke B, Gelse K, Müller T, Goldring MB, Paulsen F, Schicht M.
    PLoS One; 2018 Jan; 13(9):e0203502. PubMed ID: 30235245
    [Abstract] [Full Text] [Related]

  • 5. Fibrinolytic activity in the synovial membrane of osteoarthritis.
    Matucci-Cerinic M, Lombardi A, Lotti T, Pignone A, Senesi C, Buzzi R, Aglietti P, Partsch G, Cagnoni M.
    Br J Rheumatol; 1990 Aug; 29(4):249-53. PubMed ID: 2116205
    [Abstract] [Full Text] [Related]

  • 6. Degradation of human cartilage by synovial fluid but not cytokines in vitro.
    Hollander AP, Atkins RM, Eastwood DM, Dieppe PA, Elson CJ.
    Ann Rheum Dis; 1991 Jan; 50(1):57-8. PubMed ID: 1994871
    [Abstract] [Full Text] [Related]

  • 7. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation.
    Dingle JT, Page Thomas DP, Hazleman B.
    Int J Tissue React; 1987 Jan; 9(4):349-54. PubMed ID: 3497901
    [Abstract] [Full Text] [Related]

  • 8. Interplay of matrices in cartilage synovial fluid combine under moderate & high loadings.
    Saxena RK, Agarwal K, Sahay KB, Guha SK, Dave PK.
    Indian J Med Res; 1998 Mar; 107():123-7. PubMed ID: 9599951
    [Abstract] [Full Text] [Related]

  • 9. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis.
    Busso N, Hamilton JA.
    Arthritis Rheum; 2002 Sep; 46(9):2268-79. PubMed ID: 12355473
    [No Abstract] [Full Text] [Related]

  • 10. Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?
    Saxne T, Wollheim FA, Pettersson H, Heinegård D.
    Br Med J (Clin Res Ed); 1987 Dec 05; 295(6611):1447-8. PubMed ID: 3121058
    [No Abstract] [Full Text] [Related]

  • 11. Increased levels of thymosin β4 in synovial fluid of patients with rheumatoid arthritis: association of thymosin β4 with other factors that are involved in inflammation and bone erosion in joints.
    Choi HM, Lee YA, Yang HI, Yoo MC, Kim KS.
    Int J Rheum Dis; 2011 Oct 05; 14(4):320-4. PubMed ID: 22004227
    [Abstract] [Full Text] [Related]

  • 12. Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage.
    Di Cesare PE, Carlson CS, Stolerman ES, Hauser N, Tulli H, Paulsson M.
    J Orthop Res; 1996 Nov 05; 14(6):946-55. PubMed ID: 8982138
    [Abstract] [Full Text] [Related]

  • 13. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.
    Inman RD, Harpel PC.
    J Rheumatol; 1986 Jun 05; 13(3):535-7. PubMed ID: 2942685
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
    Fujii W, Kawahito Y, Nagahara H, Kukida Y, Seno T, Yamamoto A, Kohno M, Oda R, Taniguchi D, Fujiwara H, Ejima A, Kishida T, Mazda O, Ashihara E.
    Arthritis Rheumatol; 2015 Nov 05; 67(11):2888-96. PubMed ID: 26213210
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiogenic factor from synovial fluid resembling that from tumours.
    Brown RA, Weiss JB, Tomlinson IW, Phillips P, Kumar S.
    Lancet; 1980 Mar 29; 1(8170):682-5. PubMed ID: 6103093
    [Abstract] [Full Text] [Related]

  • 18. Matrix proteins: potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis.
    Saxne T, Heinegård D.
    J Rheumatol Suppl; 1995 Feb 29; 43():71-4. PubMed ID: 7752144
    [Abstract] [Full Text] [Related]

  • 19. Chondroitin sulphate in the normal and rheumatoid synovial fluid.
    Seppälä PO, Kärkkäinen J, Lehtonen A, Mäkisara P.
    Clin Chim Acta; 1972 Feb 29; 36(2):549-53. PubMed ID: 5008811
    [No Abstract] [Full Text] [Related]

  • 20. Deposition of fibronectin in articular cartilage of canine osteoarthritic joints.
    Burton-Wurster N, Lust G.
    Am J Vet Res; 1985 Dec 29; 46(12):2542-5. PubMed ID: 4083590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.